Italia markets closed

BMY Sep 2024 43.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
3,45000,0000 (0,00%)
Alla chiusura: 02:49PM EDT
Schermo intero
Chiusura precedente3,4500
Aperto3,1800
Denaro3,6000
Lettera3,9000
Prezzo d'esercizio43,00
Scadenza2024-09-20
Min-Max giorno3,1800 - 3,4500
Contratto - Min-MaxN/D
Volume15
Open Interest311
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri